Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA) (Q42090806)
Jump to navigation
Jump to search
scientific article published on 8 June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA) |
scientific article published on 8 June 2015 |
Statements
1 reference
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA) (English)
1 reference
Gerd R Burmester
1 reference
Madura J Rangaraj
1 reference
Georgia Roane
1 reference
Charles Ludivico
1 reference
Lucy Rowell
1 reference
Eduardo F Mysler
1 reference
Andrea Rubbert-Roth
1 reference
Alain Cantagrel
1 reference
Stephen Hall
1 reference
Piotr Leszczynski
1 reference
Daniel Feldman
1 reference
Min Bao
1 reference
Claire Davies
1 reference
1 reference
1 reference
Identifiers
1 reference